COMMUNIQUÉS West-GlobeNewswire
-
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
18/06/2026 -
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
18/06/2026 -
Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering
18/06/2026 -
International Myeloma Foundation’s Black Swan Research Initiative Presents Data and Results of Phase 2 ASCENT Cure Trial at EHA 2026 Congress
18/06/2026 -
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
18/06/2026 -
Halberd Corporation Ships Latest NeuroSense AI Version, Advancing Voice-Based Behavioral Monitoring
18/06/2026 -
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
18/06/2026 -
COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO
18/06/2026 -
COUR Pharma Announces Closing of $50 Million Series B
18/06/2026 -
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
18/06/2026 -
Lite Strategy Leads Strategic Investment in LitVM
18/06/2026 -
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
18/06/2026 -
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
18/06/2026 -
Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection
18/06/2026 -
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
18/06/2026 -
Court victory paves the way for Curium’s plans to provide targeted radioligand therapy to U.S. patients with GEP-NETs
18/06/2026 -
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
18/06/2026 -
Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
18/06/2026 -
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
18/06/2026
Pages